FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328129504> ?p ?o ?g. }

• W4328129504 endingPage "235" @default.
• W4328129504 startingPage "219" @default.
• W4328129504 abstract "Glypicans (GPC1-6) are associated with tumorigenic processes and their involvement in neoplastic behavior has been discussed in different cancer types. Here, a cancer-wide GPC expression study, using clinical cancer patient data in The Cancer Genome Atlas, reveals net upregulation of GPC1 and GPC2 in primary solid tumors, whereas GPC3, GPC5 and GPC6 display lowered expression pattern compared to normal tissues. Focusing on GPC1, survival analyses of the clinical cancer patient data reveal statistically significant correlation between high expression of GPC1 and poor prognosis in 10 particular cancer types i.e., bladder urothelial carcinoma, brain lower grade glioma, liver hepatocellular carcinoma, colon adenocarcinoma, kidney renal clear cell carcinoma, lung adenocarcinoma, mesothelioma, ovarian serous cystadenocarcinoma, uterine corpus endometrial carcinoma and uveal melanoma. In vitro studies targeting GPC1 expression by CRISPR/Cas9 or siRNA or treatment with an anti-GPC1 antibody resulted in attenuation of proliferation of cancer cells from bladder carcinoma, glioma and hepatocellular carcinoma patients (T24, U87 and HepG2 cells). Further, overexpression of GPC1 exhibited a significant and negative correlation between GPC1 expression and proliferation of T24 cells. Attempt to reveal the mechanism through which downregulation of GPC1 leads to attenuation of tumor growth using systematic Ingenuity Pathway Analysis indicate that suppression of GPC1 results in ECM-mediated inhibition of specific pro-cancer signaling pathways involving TGF-β and p38 MAPK. Identified differential expression and pleiotropic effects of GPCs in specific cancer types emphasize their potential of as novel diagnostic tools and prognostic factors and open doors for future GPC targeted therapy." @default.
• W4328129504 created "2023-03-22" @default.
• W4328129504 creator A5003230345 @default.
• W4328129504 creator A5012706476 @default.
• W4328129504 creator A5027060335 @default.
• W4328129504 creator A5061933115 @default.
• W4328129504 date "2023-03-21" @default.
• W4328129504 modified "2023-09-25" @default.
• W4328129504 title "Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior" @default.
• W4328129504 cites W1055306509 @default.
• W4328129504 cites W2013597519 @default.
• W4328129504 cites W2026919853 @default.
• W4328129504 cites W2058064181 @default.
• W4328129504 cites W2066464689 @default.
• W4328129504 cites W2073166172 @default.
• W4328129504 cites W2088697866 @default.
• W4328129504 cites W2104906501 @default.
• W4328129504 cites W2120659785 @default.
• W4328129504 cites W2131466739 @default.
• W4328129504 cites W2162143298 @default.
• W4328129504 cites W2163780502 @default.
• W4328129504 cites W2167755334 @default.
• W4328129504 cites W2179438025 @default.
• W4328129504 cites W2230320310 @default.
• W4328129504 cites W2364999181 @default.
• W4328129504 cites W2418536297 @default.
• W4328129504 cites W2441351280 @default.
• W4328129504 cites W2460110786 @default.
• W4328129504 cites W2573530098 @default.
• W4328129504 cites W2595566957 @default.
• W4328129504 cites W2746561055 @default.
• W4328129504 cites W2750227353 @default.
• W4328129504 cites W2756249095 @default.
• W4328129504 cites W2766710074 @default.
• W4328129504 cites W2783840192 @default.
• W4328129504 cites W2791746119 @default.
• W4328129504 cites W2802232137 @default.
• W4328129504 cites W2898595038 @default.
• W4328129504 cites W2918849193 @default.
• W4328129504 cites W2954910819 @default.
• W4328129504 cites W2958076402 @default.
• W4328129504 cites W2972865130 @default.
• W4328129504 cites W3000074109 @default.
• W4328129504 cites W3010492571 @default.
• W4328129504 cites W3015871015 @default.
• W4328129504 cites W3016077653 @default.
• W4328129504 cites W3022766902 @default.
• W4328129504 cites W3083474699 @default.
• W4328129504 cites W3084054647 @default.
• W4328129504 cites W3094903561 @default.
• W4328129504 cites W3109443969 @default.
• W4328129504 cites W3111257558 @default.
• W4328129504 cites W3136131935 @default.
• W4328129504 cites W3163780706 @default.
• W4328129504 cites W3174273655 @default.
• W4328129504 cites W3197765250 @default.
• W4328129504 cites W3199720155 @default.
• W4328129504 cites W3206746305 @default.
• W4328129504 cites W4200451698 @default.
• W4328129504 cites W4220655386 @default.
• W4328129504 cites W4286007757 @default.
• W4328129504 cites W4291340405 @default.
• W4328129504 cites W4295789930 @default.
• W4328129504 cites W4304694204 @default.
• W4328129504 cites W4306160611 @default.
• W4328129504 cites W4307271725 @default.
• W4328129504 cites W4313509651 @default.
• W4328129504 doi "https://doi.org/10.18632/oncotarget.28388" @default.
• W4328129504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36944188" @default.
• W4328129504 hasPublicationYear "2023" @default.
• W4328129504 type Work @default.
• W4328129504 citedByCount "0" @default.
• W4328129504 crossrefType "journal-article" @default.
• W4328129504 hasAuthorship W4328129504A5003230345 @default.
• W4328129504 hasAuthorship W4328129504A5012706476 @default.
• W4328129504 hasAuthorship W4328129504A5027060335 @default.
• W4328129504 hasAuthorship W4328129504A5061933115 @default.
• W4328129504 hasBestOaLocation W43281295041 @default.
• W4328129504 hasConcept C104317684 @default.
• W4328129504 hasConcept C121608353 @default.
• W4328129504 hasConcept C126322002 @default.
• W4328129504 hasConcept C127561419 @default.
• W4328129504 hasConcept C142724271 @default.
• W4328129504 hasConcept C2776231280 @default.
• W4328129504 hasConcept C2778019345 @default.
• W4328129504 hasConcept C2778227246 @default.
• W4328129504 hasConcept C2781182431 @default.
• W4328129504 hasConcept C502942594 @default.
• W4328129504 hasConcept C55493867 @default.
• W4328129504 hasConcept C71924100 @default.
• W4328129504 hasConcept C86803240 @default.
• W4328129504 hasConcept C96232424 @default.
• W4328129504 hasConceptScore W4328129504C104317684 @default.
• W4328129504 hasConceptScore W4328129504C121608353 @default.
• W4328129504 hasConceptScore W4328129504C126322002 @default.
• W4328129504 hasConceptScore W4328129504C127561419 @default.
• W4328129504 hasConceptScore W4328129504C142724271 @default.
• W4328129504 hasConceptScore W4328129504C2776231280 @default.

• next